10:53 AM ET
10-Q
Financial Results
XBiotech Q3 2026 Results: Net Loss of $4.46M, Loss Narrows
XBiotech Inc. reported a net loss of $16.7 million for the first nine months of 2026, a slight improvement from the $18.6 million loss in the prior year period. The company's cash position decreased to $105.0 million as of September 30, 2026, while operating expenses were reduced by approximately 32% year-over-year.
- Key figure
- Net loss $4.46M